Mapping and Characterization of Alveolar Cells During Smoking and Chronic Obstructive Disease
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre Hospitalier Intercommunal Creteil
About this trial
To evaluate the regenerative capacities of mesenchymal cells composing the microenvironment of alveolar type 2 cells in a population of patients, undergoing thoracic surgery for suspected cancer, who are smokers with and without COPD compared to non-smokers patients
Eligibility criteria
Qualifiers
Age ≥ 18
Patient undergoing lung resection surgery (lobectomy, pneumonectomy, segmentectomy) for cancer or suspected cancer
Acceptance to participate in the protocol
Affiliated to a social security plan
Disqualifiers
Chronic autoimmune disease
Patient under guardianship or curators
Neo-adjuvant chemotherapy
History of thoracic radiotherapy
Trial design
Treatments tested in this trial
- Thoracic resection surgery
Treatment groups
186 Participants
are divided into 1 treatment groupLocations
4Rousseau-Bussac94000, Créteil France
HEGP75015, Paris France
Hopital Cochin75014, Paris France
Hopital Tenon75020, Paris France
Sponsors and collaborators
Centre Hospitalier Intercommunal Creteil
Lead sponsor
Henri Mondor University Hospital
Collaborator
Institut National de la Santé Et de la Recherche Médicale, France
Collaborator
Source ClinicalTrials.gov